Skip to NavigationSkip to content

News

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared with 2018, while...
Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis in children...
The FDA has made MDMA treatment for PTSD more accessible by putting it on its Expanded Access program.
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed to meet its...
14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE).
A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to persuade physicians to prescribe...
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders,...
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the recommendation of Astellas’ Xospata (...
Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its efficacy in the...
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the US, Canada and Europe.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches